439 related articles for article (PubMed ID: 24602414)
1. The role of microRNAs in melanoma.
Luo C; Weber CE; Osen W; Bosserhoff AK; Eichmüller SB
Eur J Cell Biol; 2014; 93(1-2):11-22. PubMed ID: 24602414
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs in malignant melanoma.
Völler D; Ott C; Bosserhoff A
Clin Biochem; 2013 Jul; 46(10-11):909-17. PubMed ID: 23360785
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA regulation of melanoma progression.
Bonazzi VF; Stark MS; Hayward NK
Melanoma Res; 2012 Apr; 22(2):101-13. PubMed ID: 22209751
[TBL] [Abstract][Full Text] [Related]
4. Aberrations in the micro-RNA biogenesis machinery and the emerging roles of micro-RNAs in the pathogenesis of cutaneous malignant melanoma.
Leibowitz-Amit R; Sidi Y; Avni D
Pigment Cell Melanoma Res; 2012 Nov; 25(6):740-57. PubMed ID: 22958787
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-221 and -222 pathway controls melanoma progression.
Felicetti F; Errico MC; Segnalini P; Mattia G; Carè A
Expert Rev Anticancer Ther; 2008 Nov; 8(11):1759-65. PubMed ID: 18983236
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs as potential diagnostic and prognostic biomarkers in melanoma.
Mirzaei H; Gholamin S; Shahidsales S; Sahebkar A; Jaafari MR; Mirzaei HR; Hassanian SM; Avan A
Eur J Cancer; 2016 Jan; 53():25-32. PubMed ID: 26693896
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-mediated regulation of melanoma.
Sun V; Zhou WB; Majid S; Kashani-Sabet M; Dar AA
Br J Dermatol; 2014 Aug; 171(2):234-41. PubMed ID: 24665835
[TBL] [Abstract][Full Text] [Related]
8. Melanoma genetics: the other side.
Bis S; Tsao H
Clin Dermatol; 2013; 31(2):148-55. PubMed ID: 23438378
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA expression signatures in solid malignancies.
Galasso M; Sandhu SK; Volinia S
Cancer J; 2012; 18(3):238-43. PubMed ID: 22647360
[TBL] [Abstract][Full Text] [Related]
10. Signatures of microRNAs and selected microRNA target genes in human melanoma.
Philippidou D; Schmitt M; Moser D; Margue C; Nazarov PV; Muller A; Vallar L; Nashan D; Behrmann I; Kreis S
Cancer Res; 2010 May; 70(10):4163-73. PubMed ID: 20442294
[TBL] [Abstract][Full Text] [Related]
11. The roles of microRNA in cancer and apoptosis.
Lynam-Lennon N; Maher SG; Reynolds JV
Biol Rev Camb Philos Soc; 2009 Feb; 84(1):55-71. PubMed ID: 19046400
[TBL] [Abstract][Full Text] [Related]
12. Deep sequencing analysis of microRNA expression in human melanocyte and melanoma cell lines.
Ding N; Wang S; Yang Q; Li Y; Cheng H; Wang J; Wang D; Deng Y; Yang Y; Hu S; Zhao H; Fang X
Gene; 2015 Nov; 572(1):135-145. PubMed ID: 26164755
[TBL] [Abstract][Full Text] [Related]
13. miRNAs in Melanoma: Tumor Suppressors and Oncogenes with Prognostic Potential.
Wozniak M; Mielczarek A; Czyz M
Curr Med Chem; 2016; 23(28):3136-3153. PubMed ID: 27666934
[TBL] [Abstract][Full Text] [Related]
14. Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy.
Drebber U; Lay M; Wedemeyer I; Vallböhmer D; Bollschweiler E; Brabender J; Mönig SP; Hölscher AH; Dienes HP; Odenthal M
Int J Oncol; 2011 Aug; 39(2):409-15. PubMed ID: 21567082
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of melanoma deregulated miRNAs in the medaka and Xiphophorus pigment cell cancer models.
Mishra RR; Kneitz S; Schartl M
Comp Biochem Physiol C Toxicol Pharmacol; 2014 Jun; 163():64-76. PubMed ID: 24462553
[TBL] [Abstract][Full Text] [Related]
16. Lin28B promotes melanoma growth by mediating a microRNA regulatory circuit.
Zhang Z; Zhang S; Ma P; Jing Y; Peng H; Gao WQ; Zhuang G
Carcinogenesis; 2015 Sep; 36(9):937-45. PubMed ID: 26071398
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA in non-melanoma skin cancer.
Sand M; Sand D; Altmeyer P; Bechara FG
Cancer Biomark; 2012; 11(6):253-7. PubMed ID: 23248183
[TBL] [Abstract][Full Text] [Related]
18. The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies.
Corsini LR; Bronte G; Terrasi M; Amodeo V; Fanale D; Fiorentino E; Cicero G; Bazan V; Russo A
Expert Opin Ther Targets; 2012 Apr; 16 Suppl 2():S103-9. PubMed ID: 22443195
[TBL] [Abstract][Full Text] [Related]
19. Disturbed protein-protein interaction networks in metastatic melanoma are associated with worse prognosis and increased functional mutation burden.
Schramm SJ; Li SS; Jayaswal V; Fung DC; Campain AE; Pang CN; Scolyer RA; Yang YH; Mann GJ; Wilkins MR
Pigment Cell Melanoma Res; 2013 Sep; 26(5):708-22. PubMed ID: 23738911
[TBL] [Abstract][Full Text] [Related]
20. Molecular markers in melanoma.
Kashani-Sabet M
Br J Dermatol; 2014 Jan; 170(1):31-5. PubMed ID: 23815339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
